Tokyo, Japan

Ryuya Fukunaga

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Riken Corporation. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuya Fukunaga. Retrieved from https://idiyas.com/inventor/ryuya-fukunaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryuya Fukunaga: Innovator in tRNA Modification

Introduction

Ryuya Fukunaga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of molecular biology, particularly in the modification of transfer RNA (tRNA). With a total of 2 patents, his work focuses on enhancing the efficiency of aminoacylation and the introduction of noncanonical amino acids into proteins.

Latest Patents

Fukunaga's latest patents include innovative methods for modifying tRNA. The first patent, titled "Modified tRNA containing unnatural base and use thereof," describes a method for introducing a noncanonical amino acid residue into a desired position in a protein. This method involves modifying the structure of tRNA to improve its affinity for aminoacyl-tRNA synthetase, thereby enhancing the efficiency of aminoacylation with noncanonical amino acids.

The second patent, "Mutant SepRS, and method for site-specific introduction of phosphoserine into protein using the same," details the preparation of a mutant SepRS. This mutant is designed for the site-specific introduction of phosphoserine into proteins. It is created by analyzing the structure and functions of a phosphoseryl-tRNA synthetase derived from an archaebacterium. The mutant SepRS has enhanced binding affinity with a suppressor tRNA compared to the wild type.

Career Highlights

Throughout his career, Ryuya Fukunaga has worked with esteemed organizations such as RIKEN and The University of Tokyo. His research has significantly advanced the understanding of tRNA and its applications in protein synthesis.

Collaborations

Fukunaga has collaborated with notable scientists, including Shun-ichi Sekine and Shigeyuki Yokoyama. These collaborations have further enriched his research and contributed to the scientific community.

Conclusion

Ryuya Fukunaga's innovative work in tRNA modification has the potential to revolutionize protein synthesis and expand the possibilities of molecular biology. His contributions are invaluable to the field and continue to inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…